MedTrace Logo

Acute Study to Evaluate a Novel Implantable Midfield Powered Device in Humans With Urinary Incontinence

NCT03643380 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2018-08-22

No results posted yet for this study

Summary

A pre-market, prospective, non-randomized acute feasibility study for the treatment of patients with urinary incontinence (UI) as a consequence of urinary incontinence.

Conditions

Interventions

DEVICE

AHLeveeS System

AHLeveeS System for treatment of overactive bladder

Sponsors & Collaborators

  • Neuspera Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Gommert A. van Koeveringe · Maastricht University

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-17
Primary Completion
2017-11-15
Completion
2018-01-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03643380 on ClinicalTrials.gov